ACE and familial mitral valve prolapse: On average, only one-fifth of MVP patients were treated with cardio-protective drugs, such as beta blockers, angiotensin-converting enzyme (ACE)-inhibitors, and calcium channel blockers, whereas diuretics were rarely prescribed.